Investment Strategy Analysis: Nottingham Advisors' Q3 2022 vs. Q4 2022 13F Holdings
Ava Hoppe | 28 April, 2023
Nottingham Advisors, Inc., an independent investment advisory firm based out of Buffalo, NY, recently released their 13F holdings for the third quarter of 2022 and fourth quarter of 2022. Their 13F filing with the SEC provides a snapshot of their holdings at a specific point in time, including assets managed on behalf of their clients.
This blog post aims to provide an analysis of Nottingham Advisors' investment strategy, highlighting changes in holdings between Q3 2022 and Q4 2022.
Introduction
Nottingham Advisors is an independent investment advisory firm that provides investment management services to high net worth individuals, foundations, and retirement plans. With a focus on long-term, value-oriented investing, the firm's investment philosophy centers on asset allocation, diversification, and risk management.
In this analysis, we will examine Nottingham Advisors' Q3 2022 and Q4 2022 holdings, as reported in their 13F filing with the SEC. We will explore the holdings with the greatest changes in value and the most significant new positions acquired by the firm during this time period.
Main Body
Nottingham Advisors' Q3 2022 holdings showed assets under management of $584 million, which declined to $491 million in Q4 2022. This decline was primarily due to a sharp reduction in the firm's holdings of ACWI (iShares MSCI ACWI ETF). In Q3 2022, the firm held over 580,000 shares of ACWI, with a market value of nearly $45 million. However, the firm sold off most of these shares during Q4 2022, resulting in just over 274,000 shares held, with a market value of approximately $23 million.
In contrast, Nottingham Advisors made significant purchases of JEPI (JPMorgan Equity Premium Income ETF) and IJH (iShares Core S&P Mid-Cap ETF) during Q4 2022. The firm purchased over 484,000 shares of JEPI, increasing the value of their holdings from just over $8.5 million in Q3 2022 to over $35 million in Q4 2022. Additionally, Nottingham Advisors acquired over 18,000 shares of IJH, increasing the value of their holdings from over $19 million in Q3 2022 to over $25 million in Q4 2022.
Other notable changes in holdings included a decrease in holdings of VGIT (Vanguard Intermediate-Term Government Bond ETF) and an increase in holdings of GLDM (SPDR Gold MiniShares Trust). Nottingham Advisors reduced their holdings of VGIT from just over 344,000 shares in Q3 2022 to just under 335,000 shares in Q4 2022. At the same time, they acquired over 930 shares of GLDM, increasing the value of their holdings from just over $11,000 in Q3 2022 to over $12,000 in Q4 2022.
Conclusion
Nottingham Advisors' Q3 2022 vs. Q4 2022 13F holdings reveal a strategic shift in their investment approach. The firm appears to have reduced their exposure to ACWI while concurrently increasing their holdings of JEPI and IJH. These decisions align with the firm's long-term value-oriented investment philosophy, as they seek to allocate capital to companies that are poised to provide growth and stability over an extended period.
While Nottingham Advisors' changes in holdings may not be representative of broader market trends, they do offer insights into the firm's strategy and decision-making processes. As with any investment strategy, it is essential to consider a range of factors, including market trends, risk tolerance, and investment goals, before making investment decisions.
In summary, Nottingham Advisors' Q3 2022 vs. Q4 2022 13F holdings provide valuable insights into the firm's investment strategy. By examining their changes in holdings, we can gain a better understanding of the thinking behind their investment decisions, which may help us make more informed investment decisions in the future.
Other Posts
- Portfolio Solutions' Q2 2022 vs. Q3 2022 Holdings Comparison: Changes in Value and Company Holdings
- Revolutionizing Therapeutics: Flashpoint Therapeutics Receives $10M Seed Financing from Beta Lab
- Point72 Asset Management's Q4 2022 holdings reveal shifts towards GlaxoSmithKline and Uber Technologies.
- Navigating the Waves of Change: Timber Creek Capital's Investment Strategy Evolution from Q4 2023 to Q1 2024
- JRM Investment Counsel, LLC's Q3-Q4 2022 Holdings Comparison: Insights and Implications
- Spence Asset Management Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Hoplite Capital Management, L.P. Q2 2019 vs. Q3 2019 13F Holdings Comparison
- Investor Alert: MFS Co's Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Cutler Investment Counsel LLC Q3 2022 vs. Q4 2022: Analyzing the Changes in Holdings
- Aristotle Capital Management's Q3 2022 vs. Q4 2022 13F Holdings: Analyzing the Changes